Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
LIAN Group strengthens its position in aesthetic medicine with the launch of…
Vitaura acquires and consolidates well-established entities across the territory, offering an integrated centralized management model that includes administrative, financial, and strategic marketing support. This approach allows physicians to focus exclusively on clinical activities, patient care, and professional development, while also leveraging synergies among the different clinics. Vitaura acquires and consolidates well-established entities across the territory, offering an integrated...
PR Newswire
04/12/2024
Unwrap Smiles This Christmas with UGREEN's Fun Festive Lineup
The UGREEN Uno festive lineup exemplifies UGREEN's commitment to high-quality technology combined with warmth and personality. Tailored for iPhone users, the UGREEN Uno series offers a high-powered 100W PD charger with 4 ports, the latest Qi2 magnetic wireless charging devices compatible with Apple's MagSafe, and a versatile range of hubs and cables. Products in the UGREEN Uno series come with unique emoticons on TFT screens that add a splash of playfulness during charging, transforming everyday…
PR Newswire
04/12/2024
Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the…
AJOVY ®(fremanezumab) significantly reduced monthly migraine days (MMD) and monthly headache days (MHD) versus placebo over a 12-week period in pediatric patients aged 6-17 years 1 Efficacy consistent with fremanezumabpivotal Phase 3 and Real-World Evidence studies in adults with no new emergent safety signals observed Full data presented as alate breakerat European Headache Congress (EHC) 4-7 December in Rotterdam, NetherlandsTEL AVIV, Israel, Dec.04, 2024...
Nasdaq GlobeNewswire
04/12/2024
Nicox Announces First Commercial Sale of ZERVIATE in China by Partner…
Press ReleaseNicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream First commercialized product from the Nicox-Ocumension collaboration Recent acquisitions have enhanced OcuMension's leadership in the ophthalmology field in the China marketProduct made available quickly after approval thanks to a rapid manufacturing campaign at Ocumension's state-of-the-art factoryMajor milestone for this strong...
Nasdaq GlobeNewswire
04/12/2024
Systemair AB Interim Report Q2 2024/25
First half-year, May–October 2024 First half-year, May–October 2024 Roland Kasper, President and CEO, comments: "Good occupancy in several of our factories, a favourable product mix and effects of previously implemented cost adjustments lead to a continued strong gross margin and a good operating margin of 11.0 percent. During the second quarter, which is our strongest seasonally, we have positive organic growth of +2.6 percent. All regions, except forWestern Europe, show...
PR Newswire
04/12/2024
Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational…
Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024 Halle (Saale) / Munich, Germany, December 04, 2024- Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that it will publish its third quarter financial results...
Nasdaq GlobeNewswire
04/12/2024
Valneva Announces Peer-Reviewed Publication on the Global Health and Economic…
Saint-Herblain (France), December 4, 2024–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces the publication of an article on the global health and economic burden of mosquito-borne disease chikungunya inThe British Medical Journal (BMJ), one of the world's leading peer-reviewed medical journals. The article, titled, “The Global Health and Economic Burden of Chikungunya from 2011 to 2020: A Model-Driven Analysis on the Impact of an Emerging...
Nasdaq GlobeNewswire
04/12/2024
Everest Medicines Announces Positive Results in Preliminary Analysis of Phase…
The Phase 1b/2a clinical trial of EVER001 for the treatment of pMN is an ongoing trial conducted in China. A total of 31 patients with biopsy-proven pMN who tested positive for anti-PLA2R autoantibodies were enrolled into two cohorts. The total treatment duration was 36 weeks. Based on the patient data collected by September 13th, 2024, in the low-dose cohort, the geometric least squares mean 24-hour proteinuria decreased by 78.3% at week 36 compared to baseline, while the high-dose cohort…
PR Newswire
04/12/2024
Lupus Nephritis Clinical Trial Pipeline Experiences Momentum: DelveInsight…
Key Takeaways from the Lupus Nephritis Pipeline Report Key Takeaways from the Lupus Nephritis Pipeline Report Request a sample and discover the recent advances in lupus nephritis treatment drugs @ Lupus Nephritis Pipeline Report The lupus nephritis pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage lupus nephritis drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors,...
PR Newswire
03/12/2024
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Company Announcement COPENHAGEN, Denmark; December 3, 2024 –Genmab A/S(Nasdaq: GMAB) will increase its share capital by 10,355 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1:554 shares at DKK 962.00, 3,436 shares at DKK 1,025.00, 4,942 shares at DKK 1,032.00, 305 shares...
Nasdaq GlobeNewswire
03/12/2024
Kangen Water Machine Market Surges: USD 2583.7M in 2023 to USD 4502.3M by 2030 |…
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-30R10204/Global_Kangen_Water_Machine_Market Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-30R10204/Global_Kangen_Water_Machine_Market Major Factors Driving the Growth of Kengen Water Machine Market: The Kangen Water Machine Market is experiencing robust growth, driven by increasing health consciousness and rising demand for alkaline water solutions. These machines are gaining popularity...
PR Newswire
03/12/2024
Nutraceutical Market Size to Surpass USD 895.76 Billion by 2031, Predicted CAGR…
The report from The Insight Partners, therefore, provides several stakeholders—including ingredient manufacturers, raw material suppliers, herbal extracts manufacturers, API manufacturers, retailers, distributors, wholesalers, traders, and others—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. The report from The Insight Partners, therefore, provides several stakeholders—including ingredient manufacturers, raw material...
PR Newswire
03/12/2024
Casino Group: Real estate disposals
Casino Group sells €77m of real estate assets toGroupement Les Mousquetaires Paris, 3 December 2024Casino Group has signed a binding agreement to sell a portfolio of 69 real estate assets to Groupement Les Mousquetaires, consisting mainly of car parks, service stations, supermarket premises and ancillary lots adjoining stores now operated by Groupement Les Mousquetaires.The sale price of €77m is due to be received in the first half of 2025. This transaction will reduce Casino...
Nasdaq GlobeNewswire
03/12/2024
A. Menarini Diagnostics and Sinocare Announce Exclusive Distribution Agreement…
"The partnership with A. Menarini Diagnostics is a significant milestone in our mission to make our 3rd Generation CGM Systems widely accessible to people with diabetes," stated Dr. Jiangfeng Fei, Head of CGM Business Unit, Sinocare. "We are pleased to enter into a strategic partnership with A. Menarini Diagnostics, a leader in the healthcare industry, to bring this innovative diabetes technology to a broader audience." " The partnership with A. Menarini Diagnostics is a…
PR Newswire
03/12/2024
Orthopedic Implants Market to Hit USD 26.47 Billion by 2029 with 4.8% CAGR |…
Browse in-depth TOC on "Orthopedic Implants Market"163 - Tables60 - Figures259 - Pages Browse in-depth TOC on "Orthopedic Implants Market" 163 - Tables 60 - Figures 259 - Pages The orthopedic implants market is segmented based on type into knee implants, hip implants, shoulder implants, elbow implants, foot & ankle implants, wrist implants, and other implants - knee segment is expected to hold major share of the market in 2023. The increase in number of revision knee…
PR Newswire
03/12/2024
TraceLink Announces Grant Recipients Driving Impact Across the Globe
"At TraceLink, we are deeply committed to making a positive impact on the world by supporting initiatives that enhance health, safety, and well-being," said Shabbir Dahod, President and CEO, TraceLink. "Our corporate grant program allows us to partner with exceptional organizations that reflect our core values and dedication to driving meaningful change. It's an honor to support these nonprofits as they work toward creating a safer, healthier, and more sustainable future for…
PR Newswire
03/12/2024
Upgrade of revenue and operating profit guidance
ANNOUNCEMENT NO. 285 3 December 2024Upgrade of revenue and operating profit guidance ChemoMetec sustained its positive performance in the second quarter of 2024/25 with better-than-expected sales and order intake.Based on this, the Company now expects revenue for the 2024/25 financial year in the DKK 460-475 million range, up from DKK 445-460 million in the most recent guidance, and EBITDA in the DKK 230-240 million range, up from DKK 222-230 million previously. ChemoMetec's...
Nasdaq GlobeNewswire
03/12/2024
Philips aims to advance cardiac MRI technology through AI-driven research
Collaboration intends to leverage proprietary AI technology from Philips and Mayo Clinic to target breakthroughs in ease-of-use and efficiency to bring high-quality diagnostic MRI and better care to more patients with heart diseaseAmsterdam, the Netherlands and Chicago, USA –Royal Philips(NYSE: PHG, AEX: PHIA) andMayo Clinictoday announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...
Nasdaq GlobeNewswire
03/12/2024
Canon Medical Informatics Selected by Major Non-Profit Health System to…
®Advanced Visualization enterprise platform to consolidate its 3D imaging capabilities across more than 25 sites. This transition from a multi-vendor setup to a unified, integrated solution will help enhance imaging efficiency and promote consistency throughout the health system's network.The health system, known for its commitment to high-quality and compassionate care, is implementing the Vitrea platform to optimize its advanced visualization workflows. Standardizing on Vitrea will...
Nasdaq GlobeNewswire
03/12/2024
A New Hope for Atrial Fibrillation Patients with Breakthrough Catheter…
BTL's upcoming technology features single-shot PVI for efficient pulmonary vein isolation and a versatile design that facilitates intuitive placement in diverse anatomies. This breakthrough enhances procedural reliability and consistency. The forthcoming ablation system is engineered to target all essential areas, extending beyond PVI, with a single device. Enhanced by high-density intracardiac signal acquisition for precise treatment, BTL's next-generation catheter aims to ensure optimal…
PR Newswire
03/12/2024
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial…
Company Announcement COPENHAGEN, Denmark; December 3, 2024 – Genmab A/S(Nasdaq: GMAB) – In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) made by managerial employees and their closely associated persons. The company's managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to...
Nasdaq GlobeNewswire
03/12/2024
BMC Makes an Impact at SFRMS and AIMS: Advancing Sleep and Respiratory Care
Expert Presentations on Groundbreaking Concepts Expert Presentations on Groundbreaking Concepts Dr. Julien and Mr. Ludovic delivered engaging presentations that left a lasting impression on the attendees. At the SFRMS and AIMS event, Dr Julien shared his insights on the benefits of telemedicine in sleep and respiratory care. His insights highlighted how this emerging field can improve patient management by enabling remote monitoring and timely intervention. Telemedicine is a way to improve...
PR Newswire
03/12/2024
China Clean Expo 2025, Taking Your Cleaning Business to a New Height!
With this promising outlook, CCE 2025 is expected to attract 400+ cleaning companies showcasing cutting-edge cleaning products and innovative technologies, industry big names like Nilfisk, Rubbermaid, STIHL, HAKO, Comet, LAVOR, ICE, Chaobao, AR, HAWK, Interpump, Gausium, PUDU, VIGGO, Mazzoni and more will show the future of cleaning. With this promising outlook, CCE 2025 is expected to attract 400+ cleaning companies showcasing cutting-edge cleaning products and innovative…
PR Newswire
03/12/2024
AC Health makes critical HIV care more accessible to Filipinos with USAID…
AC Health will leverage its unique ecosystem to develop, test, and scale approaches to improving and expanding HIV care and prevention services in the Philippines. AC Health will onboard qualified health service providers on the KonsultaMD platform and expand HIV awareness and screening services beyond health facilities. It will also import essential medicines and other lifesaving technologies through units IE Medica and MedEthix and make these commercially available through Generika Drugstore…
PR Newswire
03/12/2024
Altri Comunicati